CN113160889B - Cancer noninvasive early screening method based on cfDNA omics characteristics - Google Patents
Cancer noninvasive early screening method based on cfDNA omics characteristics Download PDFInfo
- Publication number
- CN113160889B CN113160889B CN202110118814.5A CN202110118814A CN113160889B CN 113160889 B CN113160889 B CN 113160889B CN 202110118814 A CN202110118814 A CN 202110118814A CN 113160889 B CN113160889 B CN 113160889B
- Authority
- CN
- China
- Prior art keywords
- cfdna
- coverage
- fragment
- omics
- extracting
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Images
Classifications
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B30/00—ICT specially adapted for sequence analysis involving nucleotides or amino acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6806—Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6869—Methods for sequencing
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C40—COMBINATORIAL TECHNOLOGY
- C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
- C40B50/00—Methods of creating libraries, e.g. combinatorial synthesis
- C40B50/06—Biochemical methods, e.g. using enzymes or whole viable microorganisms
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
- G16B20/20—Allele or variant detection, e.g. single nucleotide polymorphism [SNP] detection
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B50/00—ICT programming tools or database systems specially adapted for bioinformatics
- G16B50/30—Data warehousing; Computing architectures
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Physics & Mathematics (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Analytical Chemistry (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Theoretical Computer Science (AREA)
- Molecular Biology (AREA)
- Medical Informatics (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Bioinformatics & Computational Biology (AREA)
- Evolutionary Biology (AREA)
- Spectroscopy & Molecular Physics (AREA)
- General Engineering & Computer Science (AREA)
- Bioethics (AREA)
- Databases & Information Systems (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pathology (AREA)
- Data Mining & Analysis (AREA)
- Computer Vision & Pattern Recognition (AREA)
- Epidemiology (AREA)
- Evolutionary Computation (AREA)
- Public Health (AREA)
- Software Systems (AREA)
- Hospice & Palliative Care (AREA)
- Oncology (AREA)
- Artificial Intelligence (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
Abstract
Description
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110118814.5A CN113160889B (en) | 2021-01-28 | 2021-01-28 | Cancer noninvasive early screening method based on cfDNA omics characteristics |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110118814.5A CN113160889B (en) | 2021-01-28 | 2021-01-28 | Cancer noninvasive early screening method based on cfDNA omics characteristics |
Publications (2)
Publication Number | Publication Date |
---|---|
CN113160889A CN113160889A (en) | 2021-07-23 |
CN113160889B true CN113160889B (en) | 2022-07-19 |
Family
ID=76879009
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202110118814.5A Active CN113160889B (en) | 2021-01-28 | 2021-01-28 | Cancer noninvasive early screening method based on cfDNA omics characteristics |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN113160889B (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113838533B (en) * | 2021-08-17 | 2024-03-12 | 福建和瑞基因科技有限公司 | Cancer detection model, construction method thereof and kit |
CN114242164B (en) * | 2021-12-21 | 2023-03-28 | 苏州吉因加生物医学工程有限公司 | Analysis method, device and storage medium for whole genome replication |
CN114613436B (en) * | 2022-05-11 | 2022-08-02 | 北京雅康博生物科技有限公司 | Blood sample Motif feature extraction method and cancer early screening model construction method |
CN115662519B (en) * | 2022-09-29 | 2023-11-03 | 南京医科大学 | cfDNA fragment characteristic combination and system for predicting cancer based on machine learning |
CN115691667B (en) * | 2022-12-30 | 2023-04-18 | 北京橡鑫生物科技有限公司 | Urology early screening device, model construction method and equipment |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110189798A (en) * | 2019-06-26 | 2019-08-30 | 广州市雄基生物信息技术有限公司 | A kind of clustering method and application based on peripheral blood plasma DNA nucleosome footprint difference |
CN110739027A (en) * | 2019-10-23 | 2020-01-31 | 深圳吉因加医学检验实验室 | cancer tissue positioning method and system based on chromatin region coverage depth |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104560697A (en) * | 2015-01-26 | 2015-04-29 | 上海美吉生物医药科技有限公司 | Detection device for instability of genome copy number |
CN106295245B (en) * | 2016-07-27 | 2019-08-30 | 广州麦仑信息科技有限公司 | Method of the storehouse noise reduction based on Caffe from coding gene information feature extraction |
WO2018081130A1 (en) * | 2016-10-24 | 2018-05-03 | The Chinese University Of Hong Kong | Methods and systems for tumor detection |
EP3548632A4 (en) * | 2016-11-30 | 2020-06-24 | The Chinese University Of Hong Kong | Analysis of cell-free dna in urine and other samples |
CN107099577A (en) * | 2017-03-06 | 2017-08-29 | 华南理工大学 | Vaginal fluid humidity strip candida albicans detection method based on Hough loop truss and depth convolutional network |
CN107133496B (en) * | 2017-05-19 | 2020-08-25 | 浙江工业大学 | Gene feature extraction method based on manifold learning and closed-loop deep convolution double-network model |
EP3743518A4 (en) * | 2018-01-24 | 2021-09-29 | Freenome Holdings, Inc. | Methods and systems for abnormality detection in the patterns of nucleic acids |
US20210082111A1 (en) * | 2018-03-29 | 2021-03-18 | Sony Corporation | Information processing device, information processing method, and program |
CN108949979A (en) * | 2018-07-11 | 2018-12-07 | 深圳市海普洛斯生物科技有限公司 | A method of judging that Lung neoplasm is good pernicious by blood sample |
CN109182526A (en) * | 2018-10-10 | 2019-01-11 | 杭州翱锐生物科技有限公司 | Kit and its detection method for early liver cancer auxiliary diagnosis |
CN109360604B (en) * | 2018-11-21 | 2021-09-24 | 南昌大学 | Ovarian cancer molecular typing prediction system |
CN109680049A (en) * | 2018-12-03 | 2019-04-26 | 东南大学 | A kind of method and its application based on the dissociative DNA in blood high-flux sequence analysis affiliated individual physiological state of cfDNA |
CN109652513B (en) * | 2019-02-25 | 2022-08-23 | 元码基因科技(北京)股份有限公司 | Method and kit for accurately detecting individual mutation of liquid biopsy based on second-generation sequencing technology |
CN110211632A (en) * | 2019-05-06 | 2019-09-06 | 西安电子科技大学 | A kind of nucleotide unit point mutation detection method neural network based |
CN111081317B (en) * | 2019-12-10 | 2023-06-02 | 山东大学 | Gene spectrum-based breast cancer lymph node metastasis prediction method and prediction system |
CN111243673B (en) * | 2019-12-25 | 2021-11-19 | 北京橡鑫生物科技有限公司 | Tumor screening model, and construction method and device thereof |
CN111254211A (en) * | 2020-02-28 | 2020-06-09 | 广东药科大学 | Aquilaria plant identification method based on ITS sequence and machine learning |
CN112086129B (en) * | 2020-09-23 | 2021-04-06 | 深圳吉因加医学检验实验室 | Method and system for predicting cfDNA of tumor tissue |
-
2021
- 2021-01-28 CN CN202110118814.5A patent/CN113160889B/en active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110189798A (en) * | 2019-06-26 | 2019-08-30 | 广州市雄基生物信息技术有限公司 | A kind of clustering method and application based on peripheral blood plasma DNA nucleosome footprint difference |
CN110739027A (en) * | 2019-10-23 | 2020-01-31 | 深圳吉因加医学检验实验室 | cancer tissue positioning method and system based on chromatin region coverage depth |
Non-Patent Citations (1)
Title |
---|
Cell-free DNA analysis reveals POLR1Dmediated resistance to bevacizumab in colorectal cancer;Qing Zhou 等;《genome medicine》;20201231;第1-17页 * |
Also Published As
Publication number | Publication date |
---|---|
CN113160889A (en) | 2021-07-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN113160889B (en) | Cancer noninvasive early screening method based on cfDNA omics characteristics | |
WO2019068082A1 (en) | Dna methylation biomarkers for cancer diagnosing | |
CN113257350B (en) | ctDNA mutation degree analysis method and device based on liquid biopsy and ctDNA performance analysis device | |
KR102381252B1 (en) | Method for Prognosing Hepatic Cancer Patients Based on Circulating Cell Free DNA | |
CN113284554B (en) | Circulating tumor DNA detection system for screening micro residual focus after colorectal cancer operation and predicting recurrence risk and application | |
KR20190085667A (en) | Circulating Tumor DNA Detection Method Using Sample comprising Cell free DNA and Uses thereof | |
CN113838533B (en) | Cancer detection model, construction method thereof and kit | |
TWI679280B (en) | Non-invasive detection of bladder cancer and method for monitoring its recurrence | |
He et al. | Assessing the impact of data preprocessing on analyzing next generation sequencing data | |
Li et al. | Detection of colorectal cancer in circulating cell-free DNA by methylated CpG tandem amplification and sequencing | |
CN109830264B (en) | Method for classifying tumor patients based on methylation sites | |
CN105132407A (en) | Method for low-frequency mutant-enriched sequencing of DNA of exfoliative cells | |
CN109652513B (en) | Method and kit for accurately detecting individual mutation of liquid biopsy based on second-generation sequencing technology | |
CN115410713A (en) | Hepatocellular carcinoma prognosis risk prediction model construction based on immune-related gene | |
CN116631508B (en) | Detection method for tumor specific mutation state and application thereof | |
Fu et al. | Improving the performance of somatic mutation identification by recovering circulating tumor DNA mutations | |
Bielo et al. | Variant allele frequency: a decision-making tool in precision oncology? | |
CN113362893A (en) | Construction method and application of tumor screening model | |
WO2020049485A1 (en) | Method of treating a cancer patient without the need for a tissue biopsy | |
CN115954052B (en) | Screening method and system for monitoring sites of tiny residual focus of solid tumor | |
Lawrence et al. | Performance characteristics of mutational signature analysis in targeted panel sequencing | |
Dan et al. | Distal fecal wash host transcriptomics identifies inflammation throughout the colon and terminal ileum | |
Wilmott et al. | Tumour procurement, DNA extraction, coverage analysis and optimisation of mutation-detection algorithms for human melanoma genomes | |
CN105838720A (en) | PTPRQ gene mutant and application thereof | |
CN114724631A (en) | Chromosome copy number variation degree evaluation model, method and application |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB03 | Change of inventor or designer information |
Inventor after: Lan Xun Inventor after: Ji Jiafu Inventor after: Bu Zhaode Inventor after: Li Jie Inventor after: Chen Jiahui Inventor after: Sun Keyong Inventor after: Sun Xin Inventor before: Lan Xun Inventor before: Ji Jiafu Inventor before: Bu Zhaode Inventor before: Li Jie Inventor before: Chen Jiahui Inventor before: Sun Keyong Inventor before: Sun Xin |
|
CB03 | Change of inventor or designer information | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20220218 Address after: B215, floor 2, No. 5, Kaifa Road, Haidian District, Beijing 100089 Applicant after: Renke (Beijing) Biotechnology Co.,Ltd. Address before: No. 30 Shuangqing Road, Haidian District, Beijing 100084 Applicant before: TSINGHUA University Applicant before: BEIJING CANCER HOSPITAL (BEIJING CANCER Hospital) |
|
TA01 | Transfer of patent application right | ||
GR01 | Patent grant | ||
GR01 | Patent grant |